Merz Pharma

1Merz Worldwide
- 1.1Austria
- 1.2Switzerland
- 1.3Russia
- 1.4USA
- 1.5UK
- 1.6Mexiko
2Company
- 2 Company
- 2.1 Philosophy
- 2.2 Facts and Figures
- 2.3 Management Board
- 2.4 History
- 2.5 Merz Pharmaceuticals
- 2.6 Merz Consumer Care
- 2.7 Merz Dental
- 2.8 Merz Hygiene
- 2.9 Merz Pharma Group
- 2.10 Locations
3Research & Development
- 3 Research & Development
- 3.1 Clinical development program Neramexane/tinnitus
4Professionals
- 4 Professionals
5Health
6Beauty
- 6 Beauty
- 6.1 Wrinkles
- 6.2 Skin Care
- 6.3 Beauty from Within
7Press
- 7 Press
- 7.1 Press Releases
- 7.2 Photos & Logos
8Career
- 8 Career
- 8.1 Merz as an Employer
- 8.2 Job Opportunities
- 8.3 Directions
- 8.4 Contact

Press
- Press Releases
- Photos & Logos

Press Releases

= Information for professionals with login

Frankfurt am Main - 09.05.2012

Pierre Fabre and Merz in exclusive negotiations to collaborate in Aesthetics – Merz planning to take on Glytone® filler range

Pierre Fabre (France) and Merz Pharmaceuticals (Germany) today announced the kick-off of exclusive negotiations to collaborate in aesthetics. Initially, Merz intends to acquire Glytone’s® fillers, a unique family of hyaluronic acid injectables to reduce wrinkles and their accompanying dermo-cosmetic products.
more

Frankfurt am Main - 15.03.2012

U.S. court restricts sale of Xeomin and dermal fillers in the U.S.

The Merz Pharma Group today confirmed that its two US subsidiaries Merz Aesthetics Inc. and Merz Pharmaceuticals LLC will for now not be allowed to market Xeomin or its dermal fillers in the U.S. market without restrictions.
more

Frankfurt am Main - 26.01.2012

Change of Management at the Merz Pharma Group

A change in the Management Board of the Merz Pharma Group is taking place. Dr. Martin Zügel, Chairman of the Board, will leave the company in the course of the year to pursue other interests.
more

more press releases